28

nanotimes

Companies Facts

multiple adoptions in high volume manufacturing.” Furthermore, The Dow Chemical Company (NYSE: DOW) showcased its new solutions designed for photovoltaic manufacturers at this year’s 25th European Photovoltaic Solar Energy Conference and Exhibition (PVSEC) in Valencia, Spain (stand L3/H4/ B4, Hall 4, Feria Valencia). Dow’s photovoltaic solu- tions can help increase solar cell efficiency and solar module durability, improve device performance at lower cost, and enable widespread adoption of solar energy. Solutions being showcased include:

• Dow’s ENLIGHT™ cleaning, texturizing, imaging and metallization solutions to enhance perfor- mance in solar cell manufacturing,

• Dow’s ADCOTE™ and MOR-FREE™ adhesives for module fabrication for long-term durability with improved environmental profile,

• Dow’s new innovative ENLIGHT™ Polyolefin Encapsulant Films used as protective encapsulants help lower total module system costs and provide for improved productivity and extended reliability,

• DOWTHERM™ and SYLTHERM™ heat transfer fluid solutions for solar grade silicon production,

• Dow’s Polyglycol CF fluid for a higher quality experience in slicing silicon wafers.

http://www.photovoltaic-conference.com/ http://www.dow.com

E

MCORE Corporation (NASDAQ: EMKR) has received a Platinum Supplier Award from North-

rop Grumman Corporation (NYSE: NOC). EMCORE is a provider of compound semiconductor-based

components and subsystems for the fiber optic and solar power markets. http://www.emcore.com

O

n August 25, 2010, Emisphere Technologies, Inc. (OTCBB: EMIS) entered into a securities

purchase agreement with certain institutional inve- stors pursuant to which the Company has agreed to sell an aggregate of 3,497,528 shares of its common stock and warrants to purchase a total of 2,623,146 additional shares of its common stock for total gross proceeds of $3,532,503.28. Each unit, consisting of one share of common stock and a warrant to purchase 0.75 shares of common stock, will be sold at a purchase price of $1.01.

The warrants to purchase additional shares will be exercisable at an exercise price of $1.26 per share beginning immediately after issuance and will expire 5 years from the date they are first exercisable.

The Company also announced that, in connection with the above private placement, it has entered into a separate securities purchase agreement with MHR Fund Management LLC (together with its affiliates, „MHR“) pursuant to which the Company has agreed to sell an aggregate of 3,497,528 shares of its common stock and warrants to purchase a total of 2,623,146 additional shares of its common stock for total gross proceeds of $3,532,503.28. Each unit, consisting of one share of common stock and a war- rant to purchase 0.75 shares of common stock, will be sold at a purchase price of $1.01. The warrants to purchase additional shares will be exercisable at an exercise price of $1.26 per share beginning immedi- ately after issuance and will expire 5 years from the date they are first exercisable. Emisphere is a bio-

10-09 :: September 2010